跳至主要内容
临床试验/NCT02739230
NCT02739230已完成不适用

Comparing Pain Relief Between Exparel® Injection vs. On-Q Catheter as the Postsurgical Analgesia Following Total Knee Arthroplasty (TKA)

Rothman Institute Orthopaedics0 个研究点开始时间: 2013年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
主要终点
Total Morphine and morphine equivalent consumption

研究概览

简要总结

The goal of this research project is to evaluate the effectiveness of a novel treatment to control pain after Total Knee Arthroplasty (TKA). The proposed approach to manage pain and eliminate risks associated with catheters is the use of Exparel injection into the joint at the time of surgery.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults scheduled to undergo primary total knee replacement
  • Willing and able to provide informed consent

排除标准

  • 未提供

研究组 & 干预措施

Exparel Injection

Active Comparator

干预措施: Exparel (Drug)

On-Q intraarthicual catheter placement

Active Comparator

干预措施: On-Q pain intra-articular catheter (Drug)

结局指标

主要结局

Total Morphine and morphine equivalent consumption

时间窗: 96 hours post-op

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验